Sangamo Therapeutics, Inc(NASDAQ:SGMO) 
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a t...
Website: http://www.sangamo.com
Founded: 1995
Full Time Employees: 354
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-03
P
O 0.61
H 0.64
L 0.58
C 0.62
V 14,557,863
10EMA 0.62
20EMA 0.62
60EMA 0.62
120EMA 0.62
250EMA 0.62